What GLP-1 Drugs Are Actually Doing to Your Body Composition
Twelve kilos down in five months on Wegovy. That was the text from a friend in March, with three exclamation points and a photo of her old jeans falling off. Two months later, a different message: she was tired all the time, her squat had dropped 20 kilos, and she felt smaller but somehow weaker.
Both texts were true. Both were measuring real things. Neither one told her the part she actually needed to know.
GLP-1 drugs work. Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the next generation of compounds behind them produce more total weight loss than any non-surgical intervention researchers have studied. That part is settled. The question that matters now, especially for people who plan to be physically capable into their 60s and 70s, is what kind of weight is actually leaving the body.
The composition of the weight you lose matters more than the number
Published studies on semaglutide and tirzepatide consistently show that 25 to 40 percent of the weight lost on GLP-1 therapy is lean mass. That is not water and it is not fat. It is muscle, organ tissue, and the structural support around your bones.
For context, in a normal calorie-restricted diet without a GLP-1 drug, lean mass typically accounts for about 20 to 25 percent of weight loss. The faster and steeper the loss, the higher the lean-mass fraction tends to climb. GLP-1 therapy creates exactly the conditions for accelerated, sustained loss, which is part of why the lean-mass fraction sits on the higher end.
Run the math on a real example. If you lose 15 kilos and 30 percent of it is lean mass, you have lost 4.5 kilos of muscle. That is the kind of number that does not show up in the mirror until two years later, when stairs feel different and the deadlift bar feels heavier than it should.
Why muscle loss is the long game
Muscle is the most metabolically active tissue in your body. It is also the tissue that quietly determines how you function in your 60s, 70s, and beyond. Every kilo you lose now is a kilo you have to either rebuild later or live without.
Three things happen when muscle drops without being defended:
- Resting metabolic rate falls. Less muscle means fewer calories burned at rest, which makes weight regain easier when GLP-1 therapy ends or doses are reduced.
- Strength and physical capacity drop in proportion to lean mass. A 10 percent loss in leg muscle translates into measurable losses in stair-climbing speed, balance, and lift capacity.
- Bone density tends to follow. Bone responds to mechanical load, and load comes from muscle. When muscle thins, bone often thins with it, which compounds the long-term picture.
Peter Attia has been making this case for years on his podcast. The argument is not against GLP-1 drugs. The argument is that whatever weight loss strategy you use, you do not want to arrive at age 70 with the muscle mass of someone who has been sedentary their whole life.
What the scale and BMI never tell you
A scale measures total mass. BMI takes total mass and divides by height squared. Neither one knows the difference between a kilo of fat and a kilo of muscle, even though those two kilos behave completely differently in your body.
This is the trap of GLP-1 therapy in particular. The scale numbers look great. The BMI number looks great. The clothes fit better. Every signal you can read in your bathroom is telling you the protocol is working. Meanwhile the composition under the surface may be drifting in a direction you would not choose if you could see it.
You cannot fix what you cannot measure.
What a DEXA scan shows you
DEXA stands for Dual-Energy X-ray Absorptiometry. It measures three things in 15 minutes: how much fat you have and where it sits, how much muscle you have and how it is distributed left-to-right and limb-by-limb, and your bone density. It is the most accurate body composition measurement available outside of a research lab.
For someone on a GLP-1 protocol, the data points that matter are:
- Total lean mass in kilograms, tracked over time. This is the muscle preservation question, answered directly.
- Visceral fat in kilograms. The deep fat around your organs is the fat with the largest health impact, and DEXA quantifies it precisely.
- Appendicular lean mass index. Muscle in your arms and legs, divided by height squared. This is the standard measure used in sarcopenia research and the number worth watching as you age.
A single scan tells you where you are. The second and third scans tell you whether the protocol is doing what you want it to.
What to do with the data
A practical pattern for someone on or starting GLP-1 therapy:
- Get a baseline scan in the first month. Know your starting fat mass, lean mass, and visceral fat before the trend begins.
- Repeat at three months. If lean mass is dropping faster than 25 percent of your total weight loss, that is the signal to act: more dietary protein, more resistance training, or a conversation with your prescriber about pacing.
- Scan again at six months and twelve months. The trend line is more useful than any single number.
The training side of this is well understood. Resistance training two or three times per week, plus protein intake at the higher end of the recommended range (roughly 1.6 to 2.0 grams per kilogram of body weight per day), defends lean mass during caloric deficit. The piece most people are missing is not the protocol. It is the measurement that tells them whether the protocol is doing what they think it is.
DEXA in Budapest, starting this September
DexaVita is launching mobile DEXA scans at five fitness locations across Budapest in September 2026. Fifteen minutes, results the same day, 13,400 Ft on the waitlist intro price. Booking works the same way booking a personal training session does.
If you are taking a GLP-1 drug, planning to start one, or coming off one and trying to hold on to the muscle you built, joining the waitlist is the easiest way to get on the calendar before public booking opens.